Recipharm, a Swedish contract development and manufacturing organization, has equipped three of its facilities with serialization capabilities in line with the US regulatory requirements.

Its facilities in Brescia, Italy and Karlskoga and Uppsala, Sweden, are the latest of Recipharm’s sites to be equipped to supply serialized products to the US and take the total number of facilities able to offer serialization capabilities to nine.

Following a EUR-40 million ($47-million) investment into its company-wide implementation program in 2016, Recipharm says it has delivered more than 1.3 million serialized and aggregated packs to markets such as China, South Korea, Saudi Arabia, and Turkey where serialization regulations are currently in place.

The next facilities to be equipped will be the company’s facility in Bengaluru, India, which will supply serialized products for the US.  

Source: Recipharm